NASDAQ · Key Statistics

Achieve Life Sciences, Inc. (QUIT) P/E Ratio, ROE & Key Statistics

$6.15 NASDAQ: QUIT Market Cap $632.35M

Data as of Nov 16, 2026 (intraday, delayed) · Source: Financial Modeling Prep (methodology)

Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for Achieve Life Sciences, Inc. (QUIT), each with what it measures. Figures are trailing twelve months or the most recent reported period.

Valuation

MetricValue
P/E ratioShare price divided by earnings per share.-4.64
P/B ratioShare price divided by book value per share.2.99
P/S ratioMarket value divided by annual revenue.5776.95
PEG ratioP/E divided by the earnings growth rate.0.26
EV / EBITDAEnterprise value against earnings before interest, tax, depreciation and amortisation.-5.14
EV / RevenueEnterprise value against annual revenue.5373.66
Earnings yieldEarnings per share as a percentage of the share price — the inverse of P/E.-19.53%
Free cash flow yieldFree cash flow as a percentage of market value.-6.70%

Profitability

MetricValue
Gross marginRevenue left after the direct cost of goods sold.0.00%
Return on equityProfit as a percentage of shareholders’ equity.-225.39%
Return on assetsProfit as a percentage of total assets.-54.12%
Return on capital employedOperating profit against the capital the business uses.-34.28%

Financial health

MetricValue
Current ratioCurrent assets divided by current liabilities. Above 1 means short-term assets cover short-term bills.10.49
Quick ratioThe same, excluding inventory.10.49
Cash ratioCash alone against current liabilities.2.33
Debt to equityTotal borrowings against shareholders’ equity.0.08
Debt to assetsTotal borrowings against total assets.0.36
Interest coverageHow many times operating profit covers the interest bill.-255.46

Per share and size

MetricValue
Earnings per shareProfit attributable to each share.−$1.25
Market capitalisationShare price times shares outstanding.$632.35M
Enterprise valueMarket value plus net debt — what it would cost to buy the business outright.$612.57M

Dividend

MetricValue
Dividend yieldAnnual dividend as a percentage of the share price.0.00%

Achieve Life Sciences, Inc. (QUIT) statistics — frequently asked questions

What is Achieve Life Sciences, Inc.'s P/E ratio?

Achieve Life Sciences, Inc. (QUIT) trades on a price-to-earnings ratio of -4.64. A negative P/E means the company reported a loss, so the ratio is not a meaningful valuation measure.

What is Achieve Life Sciences, Inc.'s return on equity?

Achieve Life Sciences, Inc. (QUIT) reports a return on equity of -225.39%, meaning it generated that much profit for every dollar of shareholders' equity.

How much debt does Achieve Life Sciences, Inc. carry?

Achieve Life Sciences, Inc. (QUIT) has a debt-to-equity ratio of 0.08, which compares total borrowings with shareholders' equity.

P/E and ROE of other Medical - Pharmaceuticals stocks

RPRX P/E 41.25CORT P/E 49.69LQDA key statisticsPBH P/E 13.90HITI ROE -36.06%NSRX ROE -158.83%All Medical - Pharmaceuticals stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.